CRISPR Therapeutics AG (CRSP) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to $56.4 million.
- CRISPR Therapeutics AG's Other Gross PP&E Adjustments rose 3312.08% to $56.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.4 million, marking a year-over-year increase of 3312.08%. This contributed to the annual value of $56.4 million for FY2025, which is 3312.08% up from last year.
- As of Q4 2025, CRISPR Therapeutics AG's Other Gross PP&E Adjustments stood at $56.4 million, which was up 3312.08% from $68.8 million recorded in Q3 2025.
- In the past 5 years, CRISPR Therapeutics AG's Other Gross PP&E Adjustments registered a high of $68.8 million during Q3 2025, and its lowest value of -$79.5 million during Q2 2021.
- Over the past 5 years, CRISPR Therapeutics AG's median Other Gross PP&E Adjustments value was $43.0 million (recorded in 2023), while the average stood at $31.6 million.
- Examining YoY changes over the last 5 years, CRISPR Therapeutics AG's Other Gross PP&E Adjustments showed a top increase of 51301.21% in 2021 and a maximum decrease of 91936.75% in 2021.
- CRISPR Therapeutics AG's Other Gross PP&E Adjustments (Quarter) stood at -$13.1 million in 2021, then surged by 271.58% to $22.5 million in 2022, then skyrocketed by 46.77% to $33.0 million in 2023, then increased by 28.18% to $42.4 million in 2024, then surged by 33.12% to $56.4 million in 2025.
- Its last three reported values are $56.4 million in Q4 2025, $68.8 million for Q3 2025, and $65.3 million during Q2 2025.